Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders
Franz X. Vollenweider, Katrin H. Preller
Nature reviews. Neuroscience (2020) Vol. 21, Iss. 11, pp. 611-624
Closed Access | Times Cited: 406

Showing 1-25 of 406 citing articles:

Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo
Ling-Xiao Shao, Clara Liao, Ian Gregg, et al.
Neuron (2021) Vol. 109, Iss. 16, pp. 2535-2544.e4
Open Access | Times Cited: 359
Psychedelics promote plasticity by directly binding to BDNF receptor TrkB
Rafael Moliner, Mykhailo Girych, Cecilia A. Brunello, et al.
Nature Neuroscience (2023) Vol. 26, Iss. 6, pp. 1032-1041
Open Access | Times Cited: 225
Towards an understanding of psychedelic-induced neuroplasticity
Abigail E. Calder, Gregor Hasler
Neuropsychopharmacology (2022) Vol. 48, Iss. 1, pp. 104-112
Open Access | Times Cited: 173
Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics
Cato M. H. de Vos, Natasha L. Mason, Kim P. C. Kuypers
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 168
The neural basis of psychedelic action
Alex C. Kwan, David E. Olson, Katrin H. Preller, et al.
Nature Neuroscience (2022) Vol. 25, Iss. 11, pp. 1407-1419
Closed Access | Times Cited: 166
Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics
Lily R. Aleksandrova, Anthony G. Phillips
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 11, pp. 929-942
Closed Access | Times Cited: 161
A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain
Nakul Ravi Raval, Annette Johansen, Lene Lundgaard Donovan, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 835-835
Open Access | Times Cited: 147
Models of psychedelic drug action: modulation of cortical-subcortical circuits
Manoj K. Doss, Maxwell B. Madden, Andrew Gaddis, et al.
Brain (2021) Vol. 145, Iss. 2, pp. 441-456
Open Access | Times Cited: 143
Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review
Michiel van Elk, David B. Yaden
Neuroscience & Biobehavioral Reviews (2022) Vol. 140, pp. 104793-104793
Open Access | Times Cited: 106
Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis
Kwonmok Ko, Emma I Kopra, Anthony J. Cleare, et al.
Journal of Affective Disorders (2022) Vol. 322, pp. 194-204
Closed Access | Times Cited: 84
Shared and Distinct Brain Regions Targeted for Immediate Early Gene Expression by Ketamine and Psilocybin
Pasha A. Davoudian, Ling-Xiao Shao, Alex C. Kwan
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 3, pp. 468-480
Open Access | Times Cited: 77
The Neuropsychology of Anxiety
Neil McNaughton, Jeffrey A. Gray
Oxford University Press eBooks (2024)
Closed Access | Times Cited: 73
Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex
Manesh Girn, Leor Roseman, Boris C. Bernhardt, et al.
NeuroImage (2022) Vol. 256, pp. 119220-119220
Open Access | Times Cited: 72
A complex systems perspective on psychedelic brain action
Manesh Girn, Fernando E. Rosas, Richard E. Daws, et al.
Trends in Cognitive Sciences (2023) Vol. 27, Iss. 5, pp. 433-445
Closed Access | Times Cited: 42
Are “mystical experiences” essential for antidepressant actions of ketamine and the classic psychedelics?
Kenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience (2024)
Open Access | Times Cited: 28
Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis
Athina-Marina Metaxa, Mike Clarke
BMJ (2024), pp. e078084-e078084
Open Access | Times Cited: 17
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Tamar Glatman Zaretsky, Kathleen M. Jagodnik, Robert Barsic, et al.
Current Neuropharmacology (2024) Vol. 22, Iss. 4, pp. 636-735
Open Access | Times Cited: 15
Uncovering Psychedelics: From Neural Circuits to Therapeutic Applications
Alberto Melani, Marco Bonaso, Letizia Biso, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 130-130
Open Access | Times Cited: 1
Consciousness, Religion, and Gurus: Pitfalls of Psychedelic Medicine
Matthew W. Johnson
ACS Pharmacology & Translational Science (2020) Vol. 4, Iss. 2, pp. 578-581
Open Access | Times Cited: 82
A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics
Neil K. Savalia, Ling-Xiao Shao, Alex C. Kwan
Trends in Neurosciences (2020) Vol. 44, Iss. 4, pp. 260-275
Open Access | Times Cited: 80
Awe as a Pathway to Mental and Physical Health
María Monroy, Dacher Keltner
Perspectives on Psychological Science (2022) Vol. 18, Iss. 2, pp. 309-320
Open Access | Times Cited: 67
Dose–response relationships of psilocybin-induced subjective experiences in humans
Tim Hirschfeld, Timo Torsten Schmidt
Journal of Psychopharmacology (2021) Vol. 35, Iss. 4, pp. 384-397
Open Access | Times Cited: 66
Psilocybin and MDMA for the treatment of trauma-related psychopathology
Catherine Bird, Nadav Liam Modlin, James Rucker
International Review of Psychiatry (2021) Vol. 33, Iss. 3, pp. 229-249
Open Access | Times Cited: 63
Classic Psychedelic Drugs: Update on Biological Mechanisms
Franz X. Vollenweider, John Smallridge
Pharmacopsychiatry (2022) Vol. 55, Iss. 03, pp. 121-138
Open Access | Times Cited: 63
The clinical pharmacology and potential therapeutic applications of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT)
Johannes T. Reckweg, Malin V. Uthaug, Attila Szabó, et al.
Journal of Neurochemistry (2022) Vol. 162, Iss. 1, pp. 128-146
Open Access | Times Cited: 58
Page 1 - Next Page

Scroll to top